Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EITRFARMA AS
AS
Active
Org 922723834
Fageråsen 39B, 5093
Bergen
All other professional, scientific and technical activities n.e.c.
· NACE 7499
Est. 2019
0 employees
Watchlist
Share
Norway
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
EITRFARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
330
41
114
0
127
Staff expenses
−0
−0
−0
−0
−0
EBITDA
84
−44
66
−51
88
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
84
−44
66
−51
88
Net financials
−4
0
0
0
0
Profit before tax
80
−44
66
−51
88
Tax
25
−0
15
−0
8
Net profit
55
−44
52
−51
80
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
214
115
110
36
146
Equity
89
54
40
−12
68
Long-term debt
0
0
0
70
70
Short-term debt
125
60
70
−22
8
Total debt
125
60
70
48
78
Financial ratios
5-year trend
EBITDA margin
69.1%
This company
15.8%
Market median
+337% vs market
2020
2024
Equity ratio
46.6%
This company
38.2%
Market median
+22% vs market
2020
2024
Return on equity
117.0%
This company
18.4%
Market median
+536% vs market
2020
2024
Net profit margin
62.8%
This company
8.1%
Market median
+675% vs market
2020
2024
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
2020
2024
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on EITRFARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network